The effect of MS14 on Th2 cytokines pattern in Balb/C mice

References

• Kang, H., Ahn, K., Cho, C., Bae, H. Immunomodulatory effect of astragali radix extract on murine Th1/Th2 cell lineage development. Biol. Pharm. Bull. 2004, 12, 1946–1950.
   Google Scholar
• Yang, S.H., Hong, C.Y., Yu, C.L. Decreased serum IgE level, decreased IFN-gamma and IL-5 but increased IL-10 production, and suppressed cyclooxygenase 2 mRNA expression in patients with perennial allergic rhinitis after treatment with a new mixed formula of Chinese herbs. Int. Immunopharmacol. 2001, 1, 1173–1182.
   PubMed Web of Science ®Google Scholar
• Shokrgozar, M. A., Sarial, S., Amirzargar, A., Shokri, F., Rezaei, N., Arjang, Z., Radfar, J., Yousefi-Behzadi, M., Ali Sahraian, M., Lotfi, J. IL-2, IFN-γ, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. J. Clin. Immunol. 2009, 29, 747–751.
   PubMed Web of Science ®Google Scholar
• Huang, W.C., Kuo, M. L., Li, M.L., Yang, R.C., Liou, C.J., Shen, J.J. The extract of gynostemma pentaphyllum enhanced the production of antibodies and cytokines in mice. Yakugaku Zasshi. 2007, 5, 889–896.
   Google Scholar
• Vogels, M.T., van der Meer, J.W. Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob. Agents Chemother. 1992, 36, 1–5.
   PubMed Web of Science ®Google Scholar
• Srivastava, K., Teper, A., Zhang, T. Immunomodulatory effect of the antiasthma Chinese herbal formula MSSM-002 on TH2 cells. Allergy and Clinical Immunology. 2003, 113, 68–76.
   Web of Science ®Google Scholar
• Shokri, H., Asadi, F., Bahonar, A.R., Khosravi, A.R. The Role of Zataria multiflora Essence (Iranian herb) on Innate Immunity of Animal Model. Iran. J. Immunol. 2006, 3, 164–168.
   PubMedGoogle Scholar
• Ho, C.Y., Lau, C.B., Kim, C.F., Leung, K.N., Fung, K.P., Tse, T.F., Chan, H.H., Chow, M.S. Differential effect of Coriolus versicolor (Yunzhi) extract on cytokine production by murine lymphocytes in vitro. Int. Immunopharmacol. 2004, 4, 1549–1557.
   PubMed Web of Science ®Google Scholar
• Tafreshi, A.P, Ahmadi, A., Ghaffarpur, M., Mostsfavi, H., Rezaeizadeh, H., Minaie, B., Faghihzadeh, S., Naseri, M. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis. Phytother. Res. 2008, 22, 1–14.
   PubMed Web of Science ®Google Scholar
• Hajhashemi, V., Ghafghazi, T., Ahmadi, A. Investigation of subacute toxicity of MS14 natural drug in rat. Daneshvar. 2004, 11, 11–14.
   Google Scholar
• Naseri, M., Ahmadi, A., Ghareghozli, K., Nabavi, M., Faghiehzade, S., Ashtarian, N. Clinical and toxicitology evaluation of MS14 natural product in patients with Multiple sclerosis. Daneshvar. 2007, 68, 59–64.
   Google Scholar
• Pelfrey, C.M., Rudick, R.A., Cotleur, A.C., Lee, J.C., Tary-Lehmann, M., Lehmann, P.V. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J. Immunol. 2000, 165, 1641–1651.
   PubMed Web of Science ®Google Scholar
• Zhang, G.X., Yu, S., Gran, B., Rostami, A. Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J. Immunol. 2005, 175, 7202–7208.
   PubMed Web of Science ®Google Scholar
• Kleemann, R., Zadelaar, S., Kooistra, T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 2008, 79, 360–376.
   PubMed Web of Science ®Google Scholar
• Jaime Imitola, Tanuja Chitnis, Samia J. Khoury. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol. Therap. 2005, 106, 163–177.
   PubMed Web of Science ®Google Scholar
• Giuliani, F., Yong, V.W. Immune-mediated neurodegeneration and neuroprotection in MS. Int. MS J. 2003, 10, 122–130.
   PubMedGoogle Scholar
• Kips, J.C. Cytokines in asthma. Eur. Respir. J. Suppl. 2001, 34, 24s–33s.
   Google Scholar
• Scott Greenfeder , Shelby P. Umland Francis, M. Cuss Richard, W. Chapman Robert, W. Egan. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir. Res. 2001, 2, 71–79.
   PubMed Web of Science ®Google Scholar
• Lucey, D.R., Clerici, M., Shearer, G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 1996, 9, 532–562.
   PubMed Web of Science ®Google Scholar
• Wiesemann, E., Klatt, J., Wenzel, C., Heidenreich, F., Windhagen, A. Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis. Clin. Exp. Immunol. 2003, 133, 454–460.
   PubMed Web of Science ®Google Scholar
• Comabella, M., Balashov, K., Issazadeh, S., Smith, D., Weiner, H.L., Khoury, S.J. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J. Clin. Invest. 1998, 102, 671–678.
   PubMed Web of Science ®Google Scholar
• Eghtedardoost, M., Yaraee, R., Ghazanfari, T., Naseri, M. The Effect of MS14 on Candidial Sepsis in Balb/c mice. Iran. J. Infec. Dis. Trop. Med. 2009, 44, 1–6.
   Google Scholar